Home/Filings/4/0001209191-22-035078
4//SEC Filing

Burstein Jennifer 4

Accession 0001209191-22-035078

CIK 0001623526other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 5:00 PM ET

Size

5.4 KB

Accession

0001209191-22-035078

Insider Transaction Report

Form 4
Period: 2022-06-07
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2022-06-07+21,00021,000 total
    Exercise: $12.96Exp: 2032-06-06Common Stock (21,000 underlying)
Footnotes (1)
  • [F1]The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date.

Issuer

Stoke Therapeutics, Inc.

CIK 0001623526

Entity typeother

Related Parties

1
  • filerCIK 0001640069

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 5:00 PM ET
Size
5.4 KB